Influenzavirus affects individuals of all ages. It can produce repeated infections throughout life, is highly communicable, and is responsible for annual epidemics of varying severity. In an average year, 20% of children will be infected with influenzavirus; this attack rate may be substantially higher during certain epidemic years and among certain populations, such as children in day care [1] [2] [3] [4] . Although the majority of influenzavirus infections in children are self-limited, influenza may be severe, particularly in young children and children with chronic medical conditions. In children aged ,2 years, influenza may lead to hospitalizations for lower respiratory tract disease, nonspecific febrile illness, or central nervous system complications [5] [6] [7] .
Furthermore, young children shed larger quantities of influenzavirus for longer periods of time than do older children and adults, and this may contribute to the spread of influenza within a community or household [8] [9] [10] [11] [12] .
Despite these recognized complications of influenzavirus infection in young children, measuring the pediatric disease burden of interpandemic influenza on a population level has been difficult. By use of large databases and community influenza surveillance, population-based studies have documented excess hospitalizations, antibiotic use, and outpatient visits among healthy children of all ages [13] [14] [15] [16] . However, the lack of laboratory confirmation of influenza illness on an individual basis has led to uncertainty about the accuracy of these estimates [17] . Respiratory syncytial virus (RSV) is recognized to be the most frequent cause of lower respiratory tract disease leading to hospitalization in infants and young children [18] [19] [20] , and RSV often circulates concurrently with influenzavirus. Therefore, adequately controlling for this cocirculation in statistical analysis is challenging and may confound estimates of influenza disease in young children.
Influenzavirus is the only respiratory virus for which a licensed vaccine and effective oral therapy are currently available. Because disease related to influenzavirus infection is potentially preventable and treatable in young children, it is critical to differentiate the burden of winter respiratory tract disease caused by influenzavirus from that of winter respiratory tract disease caused by other respiratory viruses. We undertook a prospective, population-based study to determine the incidence of laboratory-confirmed influenza illness among otherwise healthy children aged ,5 years. Our study assessed inpatient and outpatient morbidity and covered 25 consecutive influenza seasons. 
Study design
We performed a 25-year prospective cohort study of influenzaassociated morbidity among all children enrolled at the Vanderbilt Vaccine Clinic (Nashville) at some point from 1 August 1974 through 31 July 1999. Children were followed up to determine the incidence of hospitalizations, outpatient lower respiratory tract disease, otitis media, and symptomatic outpatient illness secondary to laboratory-confirmed influenza. Culture-confirmed influenza illness was based on isolation of influenzavirus A or B from a nasal wash specimen. In selected years, preseason and postseason serologic testing was performed to determine the penetrance of influenzavirus infection in the population under surveillance. The years were selected to represent years in which A/H1N1 isolates, A/H3N2 isolates, B isolates, or a mixture of A/H3N2 and A/H1N1 isolates predominated. Seroconversion was defined as a 4-fold rise in hemagglutinin antibody-inhibiting (HAI) assay titer from preseason to postseason serum samples for the influenzavirus that circulated that season.
Study population
The vaccine clinic at Vanderbilt University Medical Center enrolls children aged ,5 years. In the clinic, healthy children participate in the evaluation of experimental viral and bacterial vaccines and serve as sentinels for respiratory and enteric diseases in the community. Most children are enrolled in the clinic at birth and followed up through infancy and early childhood, receiving all routine pediatric care from the investigators. As in a private practice, a nurse practitioner or physician takes calls from the clinic patients 24 h/day, 7 days/week. Follow-up for all children begins on the date of enrollment in the vaccine clinic and ends on the date of departure from clinic, the date of enrollment into an influenza vaccine trial, or the date of the child's fifth birthday, whichever occurs first.
Sources of data
Demographic. Detailed demographic information was obtained for all children who enrolled in the vaccine clinic by means of a questionnaire administered to each family by vaccine clinic nurses. The questionnaire included information on birth weight, gestational age, family living conditions, family size and number of siblings, race, sex, and parents' education and occupation.
Clinical. Detailed clinical information, including vital signs and signs and symptoms of clinical illness, were obtained each time a child made a routine or sick visit to the clinic. Information was obtained by a vaccine clinic nurse or physician and was recorded on a standard questionnaire. When children presented to the emergency room or were admitted to the hospital with fever or respiratory illness, vaccine clinic personnel were notified and collected clinical and virologic information for inclusion in the database.
Laboratory. Nasal washes were performed to obtain specimens for virus isolation from all children who presented to the clinic with a febrile illness, an acute respiratory illness, or acute otitis media. Nasal wash specimens were routinely cultured for respiratory syncytial virus, parainfluenzaviruses, influenzaviruses A and B, adenovirus, and enteroviruses. Nasal wash specimens were placed on ice and plated within 30 min of collection. Specimens were routinely inoculated onto primary rhesus monkey kidney cells (BioWhittaker); primary human embryonic kidney cells (BioWhittaker); a diploid fibroblast cell line, MRC-5 or WI-38 (American Type Culture Collection [ATCC]); a continuous epithelial cell line, HEp-2 or HeLa (ATCC); and MDCK, a canine kidney cell line (ATCC). Cultures were observed for 10 days and passaged, if culture results were negative, for a second 10-day period. Viruses were identified by direct fluorescent antibody or hemagglutination assay. Serum was obtained at 4 time points throughout the year from each child enrolled in the clinic and stored at 220 C. Serum antibody responses to influenzavirus were measured for all children from whom preseason and postseason serum samples were available for 4 selected years, by use of an HAI assay, as described elsewhere [21] .
Outcome measures. The primary outcome measure was any outpatient vaccine clinic visit or hospitalization associated with a clinical diagnosis of febrile illness or acute upper or lower respiratory tract disease (including acute otitis media) in conjunction with the isolation of influenzavirus from a nasal wash sample. Acute otitis media was defined as the presence of fluid in the middle ear in association with signs and symptoms of acute local or systemic illness. The condition was diagnosed by a study physician or nurse practitioner, using a pneumatic otoscope, on the basis of the obliteration of landmarks or bulging or immobility of the tympanic membrane. Febrile illness was defined as clinical symptoms and a temperature .100 F. A secondary outcome measure was any outpatient vaccine clinic visit or hospitalization associated with a clinical diagnosis of febrile illness or acute upper or lower respiratory tract disease in conjunction with a 4-fold rise in serum HAI assay response to influenzavirus in preseason and postseason serum samples.
Statistical analysis. Analyses of data were patterned after the analysis done for similar projects on the impact of respiratory syncytial and parainfluenzaviruses in this population [22, 23] . The incidence of study events was obtained by dividing the number of events by the person-years of follow-up. Incidence rates and 95% confidence intervals were obtained by use of SAS (SAS Institute) and StatXact (Cytel Software) statistical software.
Results
During the 25 years of the study, 1665 children aged ,5 years were followed up in the Vanderbilt Vaccine Clinic for an average of 1.8 years (total follow-up, 3041 person-years). The clinic population predominantly resided in urban areas and was 56% white and 40% black, with an even sex distribution (table 1) .
Viral cultures were obtained during 7140 health care visits associated with fever or respiratory tract symptoms. Positive results of testing for influenzavirus were obtained at 289 visits (4%). The attack rate of symptomatic influenza illness varied from year to year, with a low of 1 culture-positive illness per 100 children in 1978-1979 and a high of 19 culture-positive illnesses per 100 children in 1993-1994 (figure 1). Of the influen-zavirus isolates, influenzavirus A/H3N2 isolates accounted for 66% of these illnesses, influenzavirus A/H1N1 for 10%, and influenzavirus B for 24%. Influenza had a distinctly seasonal pattern, with peak activity occurring December through March (figure 2).
Because samples were obtained for culture only from children with symptoms serious enough to require medical evaluation, the 289 positive influenzavirus cultures represent the minimum number of symptomatic illnesses that can be attributed to influenza. Rates of symptomatic health care visits, acute otitis media, lower respiratory tract illness, and hospitalization due to influenza were determined for each age group, as shown in table 2. On average, 9.5% of children had a symptomatic health care visit associated with culture-positive influenza each year. Rates of acute otitis media and lower respiratory tract disease caused by influenzavirus infection were higher in children aged ,2 years, compared with the rate in children aged >2 years. Among 13 children aged ,1 year who had outpatient lower respiratory tract disease, 4 children had croup, 3 had pneumonia, 3 had bronchiolitis, 2 had tracheobronchitis, and 1 had epiglottitis. Among 9 children aged 1 to ,2 years, 4 children were given a diagnosis of croup, 3 of pneumonia, and 2 of bronchiolitis. Among the 4 children aged >2 years who received a diagnosis of lower respiratory tract disease, 1 child had epiglottitis, 1 had pneumonia, 1 had bronchiolitis, and 1 had tracheobronchitis.
Seven children, all aged ,2 years, were hospitalized with influenzavirus infection; clinical characteristics of these children are shown in table 3. All 7 children had fever. Duration of hospitalization ranged from 1 to 10 days. Two children had associated bacteremia, and these 2 children had the longest hospital stays.
Because virus isolation is a specific but insensitive method for diagnosing influenzavirus infection, serologic assays were performed on all children from whom serum samples were available in 3 selected years during which 1 of the major strains was the predominant circulating strain and 1 selected year with mixed circulation (table 4) . When children with symptomatic outpatient illness who did not have positive nasal wash cultures for influenzavirus but did have a 4-fold rise in HAI titer from preseason to postseason were included in the analysis, rates of influenzavirus-related illness increased by an average of 75% (table  4) . Annual rates of laboratory-confirmed (by positive culture or seroconversion) influenzavirus infection, including that in both symptomatic and asymptomatic children, ranged from 15% during the selected year in which influenzavirus B was predominant to 42% during the selected year in which influenzavirus A/H1N1 was predominant.
Discussion
In this 25-year prospective study of healthy children aged ,5 years, influenza illness was common and was associated with diverse clinical manifestations. On average, 9.5% of enrolled children sought health care for a symptomatic culture-positive influenza illness annually. Rates of culture-positive influenza illness varied by year, with a low of 1 per 100 children in 1979-1980, when influenzavirus A/H1N1 was predominant, to a high of 19 per 100 children in 1993-1994, when influenzavirus A/H3N2 was predominant. These estimates represent the minimum burden of disease in this population. During 4 selected years, serologic assays for influenzavirus were used as an adjunct to culture in diagnosing influenzavirus infection. During those years, clinical and overall attack rates of influenza were estimated at 20.3% and 33.8%, respectively. Reported rates in other populations are similar. In an ecologic analysis of influenza morbidity among children enrolled in the Tennessee Medicaid Program, it was estimated that 8%-15% of children aged ,5 years had outpatient visits related to influenzavirus infection annually [13] . Using information gathered by a prospective household surveillance system that included asymptomatic and symptomatic children aged ,5 years, Glezen [24] reported influenza attack rates of 35%-45%.
Children aged ,2 years were most susceptible to serious consequences of influenza in this study. The clinical presentations of influenza-related illness in these young children included pneumonia, croup, bronchiolitis, and sepsis and might not have been attributed to influenza had data from cultures not been available. Hospitalizations in children aged ,2 years occurred at a rate of 3-4 per 1000 children. The present study did not have the power to detect lower rates of hospitalization, which may have occurred for older children. Our hospitalization rate for children aged ,2 years who had culture-confirmed influenza is similar to rates generated from much larger epidemiologic studies of socioeconomically diverse populations of healthy children, with reported influenza-associated hospitalization rates ranging from 2 to 5 per 1000 healthy children aged ,2 years [13, 14, 16] . These studies are consistent in their classification of children aged ,2 years as a high-risk group for complications of influenza, with hospitalization rates similar to those for older children and for adults with high-risk medical conditions. Acute otitis media is responsible for nearly 30 million health care visits each year in the United States [25, 26] . In the present study, acute otitis media was found in .50% of patients who presented at the clinic with a culture-confirmed, symptomatic influenza illness. For every 100 children aged ,2 years, 5-6 cases of acute otitis media that could be attributed to influenza occurred annually. Because acute otitis media is the most common reason for administration of outpatient antibiotic therapy to children, reducing cases of otitis media should reduce antibiotic use and limit the development of antibiotic resistance [27] . Both inactivated and live-attenuated influenzavirus vaccines are effective in the prevention of acute otitis media in children [28] [29] [30] . In a randomized, controlled clinical trial, children aged 1-12 years who received the oral neuraminidase inhibitor oseltamivir for treatment of influenza had 44% fewer episodes of otitis media than did children who received a placebo [31] .
Data from epidemiologic studies and experimental models suggest that influenzavirus has a role in predisposition of indi- viduals to invasive bacterial diseases [32, 33] . In the present study, 3 of 7 hospitalized children with influenza had concomitant severe invasive bacterial disease. Because pneumococcal disease among infants and children has been associated with isolation of respiratory viruses after a several-week lag period [34] , it is likely that influenzavirus contributed to more invasive bacterial disease than was identified in our study. The currently available Haemophilus influenzae type b and Streptococcus pneumoniae conjugate vaccines would be expected to prevent much of the invasive bacterial disease associated with influenzavirus infection. However, the pneumococcal conjugate vaccines are expensive and currently include only 7 serotypes, which account for 86% of cases of invasive disease in the United States but only 50% of cases of invasive disease worldwide [35] . Therefore, even in the era of effective conjugate vaccines, invasive bacterial disease must be included as a potential complication of influenzavirus infection in children. Reducing serious morbidity due to influenza in infants will be challenging. Three of 7 children who were hospitalized in this study were too young to receive vaccine, which is not recommended for children aged ,6 months. Similarly, 4 of 7 hospitalized children were too young to receive antiviral agents for influenzavirus, which are approved for children beginning at age 1 year. Until prophylactic and therapeutic agents are available for infants, immunization of family members and other close contacts of infants should be encouraged, to reduce the risk of transmission of influenzavirus. Immunization of pregnant women has been suggested as a means of protecting the infant through transfer of maternal antibody [36, 37] .
Although symptomatic influenza illness was common in this population, its impact must be considered in the context of other respiratory viruses, most notably RSV, that cause morbidity in children. In another study of children aged ,2 years who were enrolled in the Vanderbilt Vaccine Clinic, the annual rate of lower respiratory tract disease secondary to RSV infection was 37 per 1000 children, compared with our estimates, in the present study, of 10 episodes of lower respiratory tract disease secondary to influenzavirus infection per 1000 children [22] . Rates of hospitalization resulting from infection with RSV in the vaccine clinic population were nearly double the rates of hospitalization resulting from influenza, at 6.5 versus 3.5 hospitalizations per 1000 children aged ,2 years [22] . Clearly, a vac- cine is needed that is effective against RSV to substantially reduce the burden of lower respiratory tract disease in young children. The present study substantiates that influenza is a common infection in healthy children aged ,5 years, of whom 9%-20% will seek health care annually for an influenza-related illness. In addition, children aged ,2 years had high rates of acute otitis media, lower respiratory tract disease, and hospitalization when they were infected with influenzavirus.
A decision analysis that used estimates similar to those generated in the present study predicted that routine influenza immunization of preschool children would be cost-effective [38] . Additional studies are needed to determine optimal preventive, diagnostic, and treatment strategies for influenza in children.
